1. Holdstock G, Bruce S: Endoscopy and gastric cancer.
Gut, 1981; 22: 673-676.
2. Sakita T: Study on early gastric cancer throughout Japan.
Gastrointest Endosc, 1983; 25: 317-43.
3. Akoh JA, Sedgwick DM, Macintyne IMC: Improving
results in the treatment of gastric carcinoma: An 11-year
audit. Br J Surg, 1991; 78: 349-51.
4. Carrea P: Human gastric carcinogenesis: a multistep and
multifactorial process-First American Cancer Award
Lecture on cancer epidemiology and prevention. Cancer
Res, 1992; 52: 6733-6740.
5. Nakamura K, Ueyama T, Yao T: Pathology and
prognosis of gastric carcinoma. Cancer, 1992; 70: 1080-
87.
6. Roder J, Böttcher K, Siewert R, Busch R, Hermanek P:
Prognostic factors in gastric carcinoma. Cancer, 1993;
72: 2089-97.
7. Msika S, Chastoma C, Houry S, Lacaine F, Huguier M:
Lymph node involvement as the only prognostic factor in
curative respected gastric carcinoma: A multivariate
analysis. World J Surg, 1989; 13: 118-23.
8. Michelassi F, Takanishi DM, Pantalone D et al: Analysis
of clinicopathologic prognostic features in patients with
gastric adenocarcinoma. Surgery, 1994; 116: 804-10.
9. Shiu MH, Moore E, Samders M et al: Influence of the
extent of resection on survival after curative treatment of
gastric carcinoma: a retrospective multivariate analysis.
Arch Surg, 1987; 122: 1347-51.
10. Moriguchi S, Kamakura T, Odaka T et al: Clinical
features of the differentiated and undifferentiated types of
advanced gastric carcinoma: Univariate and multivariate
analyses. J Surg. Oncol, 1991; 48: 202-4.
11. Lauren P: The two histological main types of gastric
carcinoma: Diffuse and so-called intestinal type
carcinomas. An attempt at histo-clinical classification.
Acta Pathol Microbial Scand 1965: 64:31-49.
12. Hamilton SR, Aaltonen L: A pathology and genetics of
tumours of digestive system. World Health
Organisation(WHO): Classification of tumors, Lyon
IARCP Press: 2000: 38
13. Hermanek P, Sobin LH: UICC.TNM Classification of
malignant tumors, 4 th ed. 2 nd rev. Berlin: Soringer.
1982
14. Mantedl H: Chi-square tests with one degree of fredom:
Extension of the Mantel-Haenzel procedure. JAMA,
1963; 58: 609-16.
15. Kaplan E, Meier P: Nonparametric estimation from
ıncomplete observation. J Am Stat Assoc, 1958: 53457-
81.
16. Japanese Research Society for Gastric Cancer: The
general rules for the gastric cancer study in surgery and
pathology: Clinical classification. Jpn J Surgery, 1981;
11: 127-135.
17. Macintyre IMC, Akoh JA: Improving survival in gastric
cancer: review of operative mortality in English language
publications from 1970. Br J.Surg, 1991; 78: 773-78.
18. Oka M, Yoshino S, Hazama S, Shimoda K, Suzuki M:
Prognostic significance of regional lymph node reaction
after curative resection of advanced gastric cancer. Br J
Surg, 1992; 79: 1091-94.
19. Haugstvedt TK, Viste A, Eide GE, Söreide O: Norwegian
multicenter study of survival and prognostic factors in
patients undergoing curative resection for gastric cancers.
Br J Surg, 1993; 80: 475-478.
20. Ovaska J, Kruuna O, Saario I, Schröder T, Lempinen T:
Surgical treatment of gastric carcinoma. The Am J Surg,
1989; l58: 467-471.
21. Maehara Y, Moriguchi S, Yoshida M, Takahashi I:
Splenectomy does not correlate with length of survival in
patients undergoing curative total gastrectomy for gastric
cancer: Univariate and multivariate analysis. Cancer,
1991; 67: 3006-9.
22. Gabbert H.E, Meier S, Gerharz CD, Hommel G: Neue
histomorphologishe Prognoseparameter beim
Magencarcinom. Der Chirurg, 1992; 63: 647-655.
23. Maehara Y, Orita H, Okuyama T: Predictors of lymph
node metastasis in early gastric cancer. Br J. Surg, 1992;
79: 245-7.
24. Tanaka A, Watanabe T, Okura K, Yasutomi T: Perineural
invasion as a predictor of recurrence of gastric cancer.
Cancer, 1994; 73: 550-5.
25. Adachi Y, Kamakura T, Mori M, Maehara Y: Role of
lymph node dissection and splenectomy in node positive
gastric carcinoma. Surgery, 1994; 116: 837-41.
26. Wanebo HJ, Kennedy BJ, Winchester DP: Gastric
carcinoma: Does lymph node dissection alter survival? J
Am Coll Surg, 1996; 183: 616-624.
27. Gall FP, Hermanek P: Die systematische erweiterte
lymphknoten dissektion in derkurauiten therapie des
megancarcinomas. Der Chirurg, 1993; 64: 1024-31.
28. Kodama Y, Sugimachi K, Soejima K, Matsusaka T:
Evaluation of extensive lymph node dissection for
carcinoma of the stomach. World J Surg, 1981; 5: 241-
248.
29. Viste A, Suanes K, Janssen CW, Mantmann M:
Prognostic significance of radical lymphadenectomy in
curative resections for gastric cancer. Eur J Surg, 1994;
160: 497-502.
30. Arak A, Kull K: Factors influencing survival of patients
after radical surgery for gastric cancer. A regional study
CERRAHPAŞA TIP DERGİSİ Cilt (Sayı) 34 (4)
184
of 406 patients over a 10-year period. Acta Oncol 1994;
33: 913-920.
31. Manzoni G, Verlato G, Guglielmi A, Laterza E:
Prognostic significance of lymph node dissection in
gastric cancer. Br J Surg, 1996; 83: 1604-1607.
32. Lee WJ, Hsu FC, Shun CT, Lee PH, Yu S.C: Surgical
treatment of gastric carcinoma: The role of lymph node
dissection. J Formus Med Assoc, 1995; 94: 221-7.
33. Siewert JR, Kestlmeier R, Busch R, Busch R, Böttcher K,
Roder JD: Benefits of D2 lymph node dissection for
patients with gastric cancer and pNo and pN1 lmph node
metastases. Br J Surg, 1996; 83: 1144-47.
34. Griffith JP, Sue Ling HM, Martın I, Dixon MF:
Preservation surgery for gastric cancer. Gut, 1995; 36:
684-90.
35. Wanebo HJ, Kennedy BJ, Winchester DP: Role of
splenectomy in gastric cancer surgery: Adverse effect of
elective splenectomy on long-term survival. J Am Coll
Surg, 1997; 185: 177-184.
Thank you for copying data from http://www.arastirmax.com